Search

Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 플라스틱
    • 바이오정밀화학
      1. 용매
      2. 화학제품
      3. 연료
    • 화장품용 기능성소재
      1. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 식품첨가제
논문

Directed evolution of a cellobiose utilization pathway in Saccharomyces cerevisiae by simultaneously engineering multiple proteins

학술지

Microbial cell factories

저자명

Eriksen, Dawn T; Hsieh, Pei Chiun Helen; Lynn, Patrick; Zhao, Huimin

초록

<P><B>Abstract</B>Background<P>The optimization of metabolic pathways is critical for efficient and economical production of biofuels and specialty chemicals. One such significant pathway is the cellobiose utilization pathway, identified as a promising route in biomass utilization. Here we describe the optimization of cellobiose consumption and ethanol productivity by simultaneously engineering both proteins of the pathway, the &beta;-glucosidase (gh1-1) and the cellodextrin transporter (cdt-1), in an example of pathway engineering through directed evolution.</P>Results<P>The improved pathway was assessed based on the strain specific growth rate on cellobiose, with the final mutant exhibiting a 47% increase over the wild-type pathway. Metabolite analysis of the engineered pathway identified a 49% increase in cellobiose consumption (1.78 to 2.65 g cellobiose/(L &middot; h)) and a 64% increase in ethanol productivity (0.611 to 1.00 g ethanol/(L &middot; h)).</P>Conclusions<P>By simultaneously engineering multiple proteins in the pathway, cellobiose utilization in <I>S. cerevisiae</I> was improved. This optimization can be generally applied to other metabolic pathways, provided a selection/screening method is available for the desired phenotype. The improved <I>in vivo</I> cellobiose utilization demonstrated here could help to decrease the <I>in vitro</I> enzyme load in biomass pretreatment, ultimately contributing to a reduction in the high cost of biofuel production.</P></P>

발행연도

2013

발행기관

Springer (Biomed Central Ltd.)

라이선스

cc-by

ISSN

1475-2859

12

페이지

pp.61

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2013-06-26

Export

About

Search

Trend